EVALUATION AND PURIFICATION OF PLASMA PLASMINOGEN Full-term newborns (FTN) plasminogen was evaluated by different techniques (affinity chromatography, immunologic technique, casein method, and chromogenic substrate). The functional activity of the FTN plasminogen was about 50% of that of the adult. This suggests the possible existence of a functional anomaly of plasminogen in FTN.
Summary EVALUATION AND PURIFICATION OF PLASMA PLASMINOGEN
Full-term newborns (FTN) plasminogen was evaluated by different techniques (affinity chromatography, immunologic technique, casein method, and chromogenic substrate). The functional activity of the FTN plasminogen was about 50% of that of the adult. This suggests the possible existence of a functional anomaly of plasminogen in FTN.
FTN plasminogen aminoacids were studied, and, besides small qualitative anomalies, a decrease in amino acid residues per mole of protein and a different N-terminal amino acid were detected.
Speculation
The existence of a functional anomaly in full-term newborns' plasminogen has been suggested. The possible role of this anomaly in the pathogenesis of the hemorraghic diseases of the neonate and in hyaline membrane disease is not known, thus, the identification of this anomaly could contribute to a better understanding of these diseases.
Functional anomalies of several proteins with coagulant activity, especially fibrinogen (5, 21, 42) and prothrombin (32, 33) , have been described in full-term newborns (FTN), but in the literature that we have reviewed, a functional anomaly of FTN plasminogen has not been described.
In this paper, FTN plasminogen was evaluated by different techniques (affinity chromatography, immunologic technique, casein method, and chromogenic substrate), and the existence of a functional anomaly in plasminogen was suggested.
MATERIALS AND METHODS
Blood samples of normal adults were collected from the cubital vein and from those of FTN (Apgar 9/10), born spontaneously with no application of analgesic-anesthesic agents, from the umbilical vein. 5 min after birth. The blood was anticoagulated with 3.8% sodium citrate (1:9. v/v. anticoagulant:blood). The samples were divided into two tubes; 250 Kallikrein inactivating units of trasylol per ml of blood were added to one of the tubes. The samples were kept in ice during all these procedures. The plasmas were obtained by centrifugation at 3000 rpm for 15 min at 4°C.
Reagents: Human plasminogen (Kabi; 25 CU/vial); alpha casein (Sigma Chemical Co.), streptokinase (SK) (Behringwerke, 5,000 U/vial; Kabi 250,000 U/vial); urokinase (UK) (Roger. 25,000 units/vial); antiplasminogen serum (Behringwerke); Sepharose 4B activated with cyanogen bromide (Pharmacia Fine Chemical); chromogenic substrate (Kabi, S-225 1).
EVALUATION OF PLASMATIC ANTIFIBRINOLYTLC ACTIVITY
To evaluate plasmatic antifibrinolytic activity, the antiplasmins (chromogenic substrate) (37) and the antistreptokinases (18) were determined.
Plasminogen was assayed by the following techniques: hemaglutination inhibition method as proposed by Wu et al. (43) and modified by Estelles et a/. (I I) by using commercial plasminogen as the standard in each experiment; the casein method of Hedner and Nilsson (19) . but using urokinase [neutralized plasma (55 units/ml)] to activate plasminogen (a reference curve of a pool of normal plasmas was plotted every day); the chromogenic substrate (S-225 I) method, in which the plasminogen was activated with an excess of SK, and under this condition, a SK-human plasminogen complex was performed, and the resulting enzymatic activity was not inhibited by plasmin inhibitors in plasma (12, 13) ; the affinity chromatography technique (9) , in which columns of 0.8 cm internal diameter were packed with 5 ml of L-lysine substituted Sepharose 4B activated with cyanogen bromide and to which 2 ml of plasmas were added. Elution was performed with E-aminocaproic acid (EACA) (0.2 M), and the plasminogen was obtained in the second peak of elution. Plasminogen quantification was performed spectrophotometrically using the extinction coefficient proposed by Zolton and Meitz (44) ; results were calculated as follows:
Plasminogen (pg/ml) --A280 -A320 ml column eluate X 1. 71 ml plasnla
x 1000
The yield of this procedure was 85 to 95% using commercial plasminogen. The homogeneity of the material obtained in the second peak was evaluated by electrophoresis in 5% polyacrylamide gel in the presence of 0.1% sodium dodecyl sulphate (SDS) in a 0.1 M phosphate (8 mA; 2 hr) (34) . Staining was accomplished with amino-black IOB. Identification of this material was carried out by the haemaglutination inhibition (43) and by the Ouchterlony techniques (25) .
Several pools of adult, commercial, and FTN plasminogens were obtained by affinity chromatography and were subjected to repeated dialysis against phosphate buffer (0.1 M; pH 7.4) for 3 days at 4OC to eliminate the EACA. All pools were adjusted to a similar protein concentration.
EVALUATION OF THE FUNCTIONAL ACTIVITY OF PURIFICATED PLASMINOGEN SAMPLES
Casein method (19) . One-tenth ml of SK (Behringwerke; 5000 units/ml) was added to I ml of purified plasminogen (52 pg/ml) and incubated for 20 min at 37OC. Then 2 ml of 1% u-casein solution were added, and after 20 min at 37'C. proteolysis was stopped by the addition of 1 ml of trichloroacetic acid (20%). Plasminogen concentration was expressed in caseinolytic units (defined in such a way that LO caseinolytic units gave an absorbance of 0.300).
The same procedure was carried out using UK as an activator [(O. 1 ml UK (500 units/ml)]/ 1 ml of purified plasminogen solution (50 to 60 pg/ml).
Chromogenic substrate. One-tenth ml UK (100 units/ml) was added to 0.2 ml of purified plasminogen solution (50 to 60 pg/ ml). The last part of this technique was made after Friberger et al. (12, 13) . The results were calculated from a standard curve prepared from adult plasminogen solution (20 to 60 pg/ml).
STUDY OF THE N-TERMINAL AMINO ACIDS OF PURIFIED PLASMINOGEN
N-Terminal plasminogen amino acids were identified by dansylation after Gros and Labounesse (15) . The dansylamino acids were identified by thin-layer chromatography on polyamide sheets (BDH Chemicals, Ltd); ammonia: acetone ( 1: 100 v/v), anf formic acid:butanol:n-heptane (1: 10: 10 v/v/v) were used as solvents.
KINETIC ACTIVATION STUDIES OF PURIFIED PLASMINOGEN
The adult and FTN plasminogen (500 pg/ml) were treated with catalytic SK (Kabi PG/SK 100:l on a molar basis) (22) . Samples of 100 p1 were removed from the digestion mixture at 5. 20, and 60 min. and 10 p1 of /3-mercaptoethanol were added; the mixture was left for 20 min at 90°C. The samples were evaluated by electrophoresis in 5% polyacrylamide gel with SDS as described previously. The molecular weights were estimated by comparison to a standard curve which was obtained by plotting the log of the molecular weights (between 340,000 and 25,000). The gels were scanned, and the bands were integrated with a densitometer. An internal standard was used to estimate protein recovery.
STUDY OF AMINO ACID COMPOSITION
To evaluate the emino acid composition of the plasminogen samples, the materials were concentrated and hydrolyzed under vaccum with 6 N HCI at 1 10°C for 18 hr. Amino acid analyses were performed using a Beckman amino acid analyzer, Multicrom B model, with a column of 60 x 0.9 cm. packed with type M-82 resin. Norleucine was used as an internal standard. The residues were calculated as mole of amino acid per mole of plasminogen (29) .
RESULTS

STUDY OF THE FlBRlNOLYSlS INtlIBITORS IN FTN
Antiplasmin activity (chromogenic substrate method) was 98.5% 
FUNCTIONAL ACTIVITY OF FTN PLASMINOGEN
The plasminogen in adults and FTN was evaluated by affinity chromatograph;and by an immunologic method. The-resulting plasmin was assayed by the casein method (urokinase was used as ;he activator) an2 by the chromogenic substrate method (streptokinase was used as the activator). Considering adult activity as loo%, FTN plasminogen protein level was 47.3% (immunologic method) and 46.6% (affinity chromatography). and FTN functional plasminogen activity was only 27.1% (casein method) and 27.3% (chromogenic substrate) (Table I) . (Fig. I) . A component with a lower molecular weight than that of plasminogen was observed in reduced FTN plasminogen samples (Fig. 2) .
The three plasminogens showed a reaction of complete identity against antiplasminogen rabbit serum (Fig. 3) .
To evaluate the functional activity of plasminogen per mg of protein, three pools (52 pg/ml) obtained by affinity chromatography from adult. FTN, and commercial plasminogens were prepared. In these pools, the functional activity (casein method. using streptokinase as the activator) per mg of protein (affinity chro--.
maiography) was evaluated on 3 consecutive days. FTN plasminogen functional activity was 34% of that of the adult and 44.3% of that of commercial plasminogen (Table 2) . Adult and FTN plasminogen functional activity was evaluated in other pools by the chromogenic substrate and casein methods (urokinase was used as the plasminogen activator). FTN plasminogen activity was 45.3% (chromogenic substrate) and 30% (casein method) compared with that of the adult.
Unactivated purified plasminogen samples showed no plasmin activity (chromogenic substrate).
Glutamic acid with traces of valine and lysine were the Nterminal amino acid residues found for the adult and commercial plasminogen, whereas valine and lysine were the most frequent N-terminal amino acid residues of the FTN plasminogen and only traces of glutamic acid were observed (Table 3) .
Finally, the amino acid composition of the three pools of plasminogen (adult, commercial, and FTN) was evaluated. Table  4 shows that in the FTN plasminogen there exist no notable differences in the proportions of amino acids in relation to the commercial and adult plasminogens. However, a relative increase in glycine and phenyl alanine and a decrease in the amino acid residues per mole of plasminogen were observed.
CATALYTIC' ACTIVATION OF PLASMINOGEN WITH STREPTOKINASE
Adult and FTN plasminogens were treated with catalytic streptokinase. Samples were removed from the digestion mixture at the times indicated and treated as described in "Materials and Methods." The quantitative scan data are shown in Table 5 . A rapid increase in plasminogen f~agments 64,000, 54.000, 25,000, and 14,000 was observed.
To identify the activation components produced during the activation of adult and FTN plasminogens, similar activation of commercial plasminogen with streptokinase was performed (Figs.  4 and 5) . and activation components similar to that of adult and FTN plasminogens were obtained. Figure 5 shows a rapid loss of plasminogen (PC-92) and the appearance of PI-64 and PI-25 fragments; these componerts are probably similar to the heavy and light chains of plasmin (14) . In addition, there appears to be adults and FTN by different techniques Plasminogen .
Affinity chromatography
Immunologic method Casein method Chromogenic substrate (pg/ml) (pg/ml)
-- (4, 16, 17) . It is known that the plasminogen level decreases in FTN (1. 10) and in premature newborns (2. 24. 27) . Although an anomaly 'in the dlasminogen function'has been described in adults (3) . in the literature that we have reviewed
only Potron el al. (26) suggest the existence of an abnormal-fetal plasminogen, but they do not prove its existence.
In our experiments, we have found a smaller amount of and less functional activity in the FTN plasminogen than in the adult plasminogen. We have also observed in the FTN plasminogen a different N-terminal amino acid, similar molecular weight evaluated by SDS polyacrylamide gel, similar kinetic activation evaluated by streptokinase; small, but notable qualitative differences in the amino acid composition, a smaller amount of amino acid residues per mole of plasminogen; and a different reduced SDS electrophoretic pattern of the plasminogen without activation. These results suggest qualitative and quantitative differences between the adult and FTN plasminogens that could be studied in depth. ' Glu-PC. NH2-terminal glutamic acid plasminogen; Lys-PG. NH2-terminal lysine plasminogen. 
I Numbers, number of moles of band per mole of plasminogen x 100.
In our experiences, the functional activity per mg of protein of the FTN plasminogen was about 30% of that of the adult. These differences were detected in plasma and purified plasminogen by using both streptokinase and urokinase as the plasminogen activator.
The plasminogen hypofunction could not be attributed to an excess of fibrinolytic inhibitors in the FTN plasma because we have not found an increase in the antiplasmins and inhibitors of the streptokinase activation. Besides, in the casein method, the plasma is acidified to eliminate the fibrinolytic inhibitors, and in the chromogenic substrate method, the activity is not inhibited by plasmin inhibitors (12, 13) . In addition, in the purified samples, in which the inhibitor is eliminated, anomalies in the FTN plasminogen were also detected.
It might be supposed that the hypofunction of the FTN plasminogen could be attributed to a technical deficiency in the purification process. However, because the FTN plasminogen has undergone a purification process identical to that of the adult and commercial plasminogens and the proportional differences of activity have been maintained among the three samples, it is very difficult to suppose that the hypofunction of plasminogen in FTN is due to an artifact resulting from purification procedures. Claeys and Vermylen (7) also described how different biologic activities exist between various fractions of purified plasminogen obtained by different authors and different methods of extraction. They suggest that this difference may be due fundamentally to the different techniques used and especially to the possible interference of the EACA that could contaminate the plasminogen sample after the elution of the column (39). It is not possible that the sample was contaminated by EACA because it had been submitted to repeated dialysis until an equilibrium between the phases was obtained. Besides, contamination with traces of plasmin did not occur in the dialysed samples because no plasminic activity was found in them.
Inasmuch as the enzymatic activity of plasminogen is associated with the light chain (30, 35) and it is the heavy chain which was retained by the column when the chromatography technique was used for its purification (28, 36) . another possibility that could explain the hypofunction found in the FTN plasminogen could be that this plasminogen was fundamentally composed of the heavy chain of its molecule. This was not likely to occur because the sample had not been reduced, and besides, the addition of trasylol in the extraction procedure would prevent the plasmin digestion of the plasrninogen obtained (14) .
Our results suggest the existence of a decrease in functional activity of the FTN plasminogen. We think that this hypofunction could be attributed: ( I ) to an abnormal FTN plasminogen synthesis; (2) to the conversion of the FTN plasminogen in Lys-plasminogen on Lys-plasmin. It does not seem likely that Lys-plasmin would cause this hypofunction because we have not found any detectable plasmin activity in the unactivated purified plasminogen obtained as measured by chromogenic substrate. 1fthe cause were Lys-plasminogen, this would have to be activated by streptokinase and urokinase with greater rapidity than if it were Gluplasminogen (6, 38, 41) , and thus, this structural anomaly would not lead to the hypofunction which has been found.
It could also be assumed that Lys-plasmin has been generated and that through a process of autolysis it would have hydrolized its light chain as occurs "in virro" (14, 35) with a l o s s of i t s functional activity. This inactive plasmin would n o t be able t o be a c t i v a t e d by s t r e p t o k i n a s e nor by u r o k i n a s e , nor would i t g i v e direct plasmin activity. H o w e v e r , this hypothesis does not seem probable because a band of m o l e c u l a r weight similar to that of p l a s m i n o g e n appears p r e d o m i n a n t l y in the reduced FTN p l a s m i nogen sample without activation, and only a small proportion of a band w i t h a molecular weight s i m i l a r t o that of the heavy chain of plasmin appears. On the other hand, the decrease in the residues of amino acids per mole of FTN plasminogen suggests t h e loss of some peptide ( a n activation p e p t i d e ? ) which would be confirmed by the d i f f e r e n t N -t e r m i n a l amino acid found in b o t h t y p e s of plasminogen ( v a l i n e in FTN plasminogen and glutamic acid in a d u l t p l a s m i n o g e n ) .
Our experiencesuggests t h e p o s s i b l e existencd of a f u n c t i o n a l anomaly in FTN plasminogen.
